share_log

Morgan Stanley Maintains Underweight on Aptiv, Lowers Price Target to $60

Benzinga ·  Nov 15 00:27  · Ratings

Morgan Stanley analyst Adam Jonas maintains Aptiv (NYSE:APTV) with a Underweight and lowers the price target from $68 to $60.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment